Thursday 13 June 2024

MES digitalising medicine production processes.

Minaris Regenerative Medicine GmbH (Minaris) is a leading contract development and manufacturing organisation for cell and gene therapies. The company has implemented a digital Manufacturing Execution System (MES), the newest version of Werum PAS-X MES by Körber, at its German site in Ottobrunn near Munich. By doing so, Minaris is converting its production management to digital processes and following the right first time principle for highest quality.

With the MES, already parallel to production, batches can be documented paperless, checked and released within the shortest possible time. “Through the ‘review by exception’ concept, we offer our customers efficient processes and more agility in a cost-effective manner”, said Renate Sporrer, COO of Minaris Regenerative Medicine GmbH.

“We will benefit from operational advantages such as faster batch releases, as well as time and cost savings. Werum PAS-X MES is an important building block for our customers to shorten their time to market.” The status of equipment can also be controlled electronically. In addition, the digital production management system enables Minaris to make a wide range of process information for clients efficiently and quickly available.

Körber's latest version Werum PAS-X MES 3.3 covers all of Minaris’ requirements, which allowed Minaris to implement the software without any customization. By using the “Continuous Evolution Stream” support model, Minaris ensures that the MES system can be updated every six months. The company will regularly benefit from new features as soon as they are released. Via an interface, PAS-X MES integrates the Enterprise Resource Planning (ERP) system into the production IT infrastructure.

@KoerberPharma @WerumKarriere #PAuto

No comments:

Post a Comment